Home » Topics » Regulatory » Patents

Patents
RSS

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics

March 17, 2022

New lysine-specific demethylase 5B inhibitors identified at FibroGen

March 17, 2022

Shengke Pharmaceuticals discovers FLT inhibitors

March 17, 2022

New PTPN11 inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

March 16, 2022

Aligos Therapeutics patents PD-1/PD-L1 interaction inhibitors

March 16, 2022

New orexin OX2 receptor agonists identified at Merck & Co.

March 16, 2022

New Toll-like receptor 9 antagonists identified at Bristol Myers Squibb

March 16, 2022

Alterity Therapeutics describes zinc and/or iron ionophores

March 16, 2022

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...